81 FR 1634 - National Cancer Institute: Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 8 (January 13, 2016)

Page Range		1634-1634
FR Document		2016-00459

Federal Register, Volume 81 Issue 8 (Wednesday, January 13, 2016)

[Federal Register Volume 81, Number 8 (Wednesday, January 13, 2016)]
[Notices]
[Page 1634]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-00459]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute: Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications/contract proposals and the 
discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the grant applications/contract 
proposals, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Purification of Cancer Cell Extracellular Vesicles.
    Date: February 10, 2016.
    Time: 11:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Rockville, MD 20850 (Telephone Conference Call).
    Contact Person: Jeffrey E. DeClue, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W238, Bethesda, MD 20892-9750, 240-276-6371, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Quantification of Redox.
    Date: February 11, 2016.
    Time: 1:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Rockville, MD 20850 (Telephone Conference Call).

    Contact Person: Nadeem Khan, Ph.D., Scientific Review Officer, 
Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W260, Bethesda, MD 20892-9750, 240-276-5856, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Biomarker Immunoassay Signal Amplification.
    Date: February 16-17, 2016.
    Time: 11:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Rockville, MD 20850 (Telephone Conference Call).
    Contact Person: Jeffrey E. DeClue, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W238, Bethesda, MD 20892-9750, 240-276-6371, 
[email protected].

    Name of Committee: National Cancer Institute Initial Review 
Group; Subcommittee F--Institutional Training and Education.
    Date: February 22-23, 2016.
    Time: 7:30 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road Bethesda, MD 20852.
    Contact Person: Timothy C. Meeker, MD, Scientific Review 
Officer, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, 7W624, Bethesda, MD 20892-9750, 240-276-6464, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: January 7, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-00459 Filed 1-12-16; 8:45 am]
 BILLING CODE 4140-01-P

1634 Federal Register / Vol. 81, No. 8 / Wednesday, January 13, 2016 / Notices

ESTIMATED ANNUALIZED BURDEN HOURS
Average
Number of
Type of Number of burden per Total annual
Form name responses per
respondent respondents response burden hour
respondent (in hours)

Cloud Pilot Survey ............................ Principal Investigator ........................ 1500 1 15/60 375

Dated: January 6, 2016. Place: National Cancer Institute Shady DEPARTMENT OF HEALTH AND
Karla Bailey, Grove, 9609 Medical Center Drive, Rockville, HUMAN SERVICES
Project Clearance Liaison, National Cancer MD 20850 (Telephone Conference Call).
Institute, NIH. Contact Person: Nadeem Khan, Ph.D., National Institutes of Health
[FR Doc. 2016–00458 Filed 1–12–16; 8:45 am] Scientific Review Officer, Research
Technology and Contract Review Branch, National Institute on Deafness and
BILLING CODE 4140–01–P
Division of Extramural Activities, National Other Communication Disorders;
Cancer Institute, NIH, 9609 Medical Center Notice of Closed Meetings
Drive, Room 7W260, Bethesda, MD 20892–
DEPARTMENT OF HEALTH AND Pursuant to section 10(d) of the
9750, 240–276–5856, nkhann3@nih.gov.
HUMAN SERVICES Federal Advisory Committee Act, as
Name of Committee: National Cancer amended (5 U.S.C. App.), notice is
National Institutes of Health Institute Special Emphasis Panel; Biomarker
hereby given of the following meetings.
Immunoassay Signal Amplification. The meetings will be closed to the
National Cancer Institute: Notice of Date: February 16–17, 2016.
public in accordance with the
Closed Meetings Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate contract
provisions set forth in sections
proposals. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Pursuant to section 10(d) of the as amended. The grant applications and
Federal Advisory Committee Act, as Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Rockville, the discussions could disclose
amended (5 U.S.C. App.), notice is confidential trade secrets or commercial
hereby given of the following meetings. MD 20850 (Telephone Conference Call).
Contact Person: Jeffrey E. DeClue, Ph.D., property such as patentable material,
The meetings will be closed to the Scientific Review Officer, Research and personal information concerning
public in accordance with the Technology and Contract Review Branch, individuals associated with the grant
provisions set forth in sections Division of Extramural Activities, National applications, the disclosure of which
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Cancer Institute, NIH, 9609 Medical Center would constitute a clearly unwarranted
as amended. The grant applications/ Drive, Room 7W238, Bethesda, MD 20892– invasion of personal privacy.
contract proposals and the discussions 9750, 240–276–6371, decluej@mail.nih.gov. Name of Committee: National Institute on
could disclose confidential trade secrets Name of Committee: National Cancer Deafness and Other Communication
or commercial property such as Institute Initial Review Group; Subcommittee Disorders Special Emphasis Panel; P50
patentable material, and personal F—Institutional Training and Education. Clinical Research Center Vocal Disorders
information concerning individuals Date: February 22–23, 2016. Review Meeting.
associated with the grant applications/ Time: 7:30 p.m. to 5:00 p.m. Date: January 28, 2016.
contract proposals, the disclosure of Agenda: To review and evaluate grant Time: 11:30 a.m. to 2:30 p.m.
applications. Agenda: To review and evaluate grant
which would constitute a clearly applications.
unwarranted invasion of personal Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road Place: National Institutes of Health,
privacy. Neuroscience Center, 6001 Executive
Bethesda, MD 20852.
Name of Committee: National Cancer Boulevard, Rockville, MD 20852 (Telephone
Contact Person: Timothy C. Meeker, MD, Conference Call).
Institute Special Emphasis Panel; Scientific Review Officer, Resources and
Purification of Cancer Cell Extracellular Contact Person: Kausik Ray, Ph.D.,
Training Review Branch, Division of Scientific Review Officer, National Institute
Vesicles. Extramural Activities, National Cancer on Deafness and Other Communication
Date: February 10, 2016. Institute, NIH, 9609 Medical Center Drive, Disorders, National Institutes of Health,
Time: 11:00 a.m. to 4:00 p.m. 7W624, Bethesda, MD 20892–9750, 240–276– Rockville, MD 20850, 301–402–3587, rayk@
Agenda: To review and evaluate contract 6464, meekert@mail.nih.gov. nidcd.nih.gov.
proposals.
Place: National Cancer Institute Shady (Catalogue of Federal Domestic Assistance This notice is being published less than 15
Program Nos. 93.392, Cancer Construction; days prior to the meeting due to the timing
Grove, 9609 Medical Center Drive, Rockville,
93.393, Cancer Cause and Prevention limitations imposed by the review and
MD 20850 (Telephone Conference Call).
Research; 93.394, Cancer Detection and funding cycle.
Contact Person: Jeffrey E. DeClue, Ph.D.,
Scientific Review Officer, Research Diagnosis Research; 93.395, Cancer Name of Committee: National Institute on
Technology and Contract Review Branch, Treatment Research; 93.396, Cancer Biology Deafness and Other Communication
Research; 93.397, Cancer Centers Support; Disorders Special Emphasis Panel; Clinical
Division of Extramural Activities, National
93.398, Cancer Research Manpower; 93.399, Trial Review.
Cancer Institute, NIH, 9609 Medical Center
Date: February 2, 2016.
asabaliauskas on DSK5VPTVN1PROD with NOTICES

Drive, Room 7W238, Bethesda, MD 20892– Cancer Control, National Institutes of Health,
HHS) Time: 2:45 p.m. to 4:45 p.m.
9750, 240–276–6371, decluej@mail.nih.gov. Agenda: To review and evaluate grant
Name of Committee: National Cancer Dated: January 7, 2016. applications.
Institute Special Emphasis Panel; Melanie J. Gray, Place: National Institutes of Health,
Quantification of Redox. Neuroscience Center, 6001 Executive
Program Analyst, Office of Federal Advisory
Date: February 11, 2016. Boulevard, Rockville, MD 20852 (Telephone
Committee Policy.
Time: 1:00 p.m. to 4:00 p.m. Conference Call).
Agenda: To review and evaluate contract [FR Doc. 2016–00459 Filed 1–12–16; 8:45 am] Contact Person: Kausik Ray, Ph.D.,
proposals. BILLING CODE 4140–01–P Scientific Review Officer, National Institute

VerDate Sep<11>2014 16:59 Jan 12, 2016 Jkt 238001 PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 E:\FR\FM\13JAN1.SGM 13JAN1

Document Created: 2016-01-13 01:00:40
Document Modified: 2016-01-13 01:00:40

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		February 10, 2016.
FR Citation		81 FR 1634

81 FR 1634 - National Cancer Institute: Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 81, Issue 8 (January 13, 2016)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health